×
Return to Life PDF
$ 40.00
Return to Life PDF quantity
$ 40.00
×
Insomnia as a Risk for Depression: A Longitudinal Epidemiologic Study on a Japanese Rural Cohort PDF
$ 40.00
Insomnia as a Risk for Depression: A Longitudinal Epidemiologic Study on a Japanese Rural Cohort PDF quantity
$ 40.00
×
National Survey of Adherence, Efficacy, and Side Effects of Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder in Taiwan PDF
$ 40.00
National Survey of Adherence, Efficacy, and Side Effects of Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder in Taiwan PDF quantity
$ 40.00
×
A Real-World Assessment of Outcomes in Schizophrenia Patients According to Treatment Response PDF
$ 40.00
A Real-World Assessment of Outcomes in Schizophrenia Patients According to Treatment Response PDF quantity
$ 40.00
×
Mood Stabilizers During Breastfeeding: A Review PDF
$ 40.00
Mood Stabilizers During Breastfeeding: A Review PDF quantity
$ 40.00
×
Hyperresponsivity to Threat Stimuli in Domestic Violence Offenders: A Functional Magnetic Resonance Imaging Study PDF
$ 40.00
Hyperresponsivity to Threat Stimuli in Domestic Violence Offenders: A Functional Magnetic Resonance Imaging Study PDF quantity
$ 40.00
×
The Effectiveness of Antidepressants in Elderly Depressed Outpatients: A Prospective Case Series Study PDF
$ 40.00
The Effectiveness of Antidepressants in Elderly Depressed Outpatients: A Prospective Case Series Study PDF quantity
$ 40.00
×
Sugar Addictive Behavior Resulting From Hypoglycemia Provoked by Insulin Misuse PDF
$ 40.00
Sugar Addictive Behavior Resulting From Hypoglycemia Provoked by Insulin Misuse PDF quantity
$ 40.00
×
Screening Physical or Sexual Abuse Victims for Substance Abuse PDF
$ 40.00
Screening Physical or Sexual Abuse Victims for Substance Abuse PDF quantity
$ 40.00
×
How Many Subjects With Major Depressive Disorder Meet Eligibility Requirements of an Antidepressant Efficacy Trial? PDF
$ 40.00
How Many Subjects With Major Depressive Disorder Meet Eligibility Requirements of an Antidepressant Efficacy Trial? PDF quantity
$ 40.00
×
What Is the Threshold for Symptomatic Response and Remission for Major Depressive Disorder, Panic Disorder, Social Anxiety Disorder, and Generalized Anxiety Disorder? PDF
$ 40.00
What Is the Threshold for Symptomatic Response and Remission for Major Depressive Disorder, Panic Disorder, Social Anxiety Disorder, and Generalized Anxiety Disorder? PDF quantity
$ 40.00
×
Relapse Prevention and Residual Symptoms: A Closer Analysis of Placebo-Controlled Continuation Studies With Escitalopram in Major Depressive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Obsessive-Compulsive Disorder PDF
$ 40.00
Relapse Prevention and Residual Symptoms: A Closer Analysis of Placebo-Controlled Continuation Studies With Escitalopram in Major Depressive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Obsessive-Compulsive Disorder PDF quantity
$ 40.00
×
Stimulant Formulations for the Treatment of Attention-Deficit/Hyperactivity Disorder PDF
$ 40.00
Stimulant Formulations for the Treatment of Attention-Deficit/Hyperactivity Disorder PDF quantity
$ 40.00
×
Predictors and Time Course of Response Among Panic Disorder Patients Treated With Cognitive-Behavioral Therapy PDF
$ 40.00
Predictors and Time Course of Response Among Panic Disorder Patients Treated With Cognitive-Behavioral Therapy PDF quantity
$ 40.00
×
Telemental Health Utilization in Commercial Health Insurance Plans in the United States From 2010 Through 2019 PDF
$ 40.00
Telemental Health Utilization in Commercial Health Insurance Plans in the United States From 2010 Through 2019 PDF quantity
$ 40.00
×
An 8-Week Randomized, Double-Blind Trial Comparing Efficacy, Safety, and Tolerability of 3 Vilazodone Dose-Initiation Strategies Following Switch From SSRIs and SNRIs in Major Depressive Disorder PDF
$ 40.00
An 8-Week Randomized, Double-Blind Trial Comparing Efficacy, Safety, and Tolerability of 3 Vilazodone Dose-Initiation Strategies Following Switch From SSRIs and SNRIs in Major Depressive Disorder PDF quantity
$ 40.00
×
Prevalence of Kratom Use and Co-Occurring Substance Use Disorders in the United States PDF
$ 40.00
Prevalence of Kratom Use and Co-Occurring Substance Use Disorders in the United States PDF quantity
$ 40.00
×
Elevated Creatine Phosphokinase in a Patient on a Long-Acting Antipsychotic: A Challenging Presentation Similar to Neuroleptic Malignant Syndrome PDF
$ 40.00
Elevated Creatine Phosphokinase in a Patient on a Long-Acting Antipsychotic: A Challenging Presentation Similar to Neuroleptic Malignant Syndrome PDF quantity
$ 40.00
×
Establishment of the National Pregnancy Registry for Atypical Antipsychotics PDF
$ 40.00
Establishment of the National Pregnancy Registry for Atypical Antipsychotics PDF quantity
$ 40.00
×
A Case-Controlled Study of Successful Aging in Older HIV-Infected Adults PDF
$ 40.00
A Case-Controlled Study of Successful Aging in Older HIV-Infected Adults PDF quantity
$ 40.00
×
Clozapine, Diabetes Mellitus, Hyperlipidemia, and Cardiovascular Risks and Mortality: Results of a 10-Year Naturalistic Study PDF
$ 40.00
Clozapine, Diabetes Mellitus, Hyperlipidemia, and Cardiovascular Risks and Mortality: Results of a 10-Year Naturalistic Study PDF quantity
$ 40.00
×
Postprandial Oxytocin Secretion Is Associated With Severity of Anxiety and Depressive Symptoms in Anorexia Nervosa PDF
$ 40.00
Postprandial Oxytocin Secretion Is Associated With Severity of Anxiety and Depressive Symptoms in Anorexia Nervosa PDF quantity
$ 40.00
×
Catatonia After Neuroleptic Malignant Syndrome Successfully Treated With Electroconvulsive Therapy PDF
$ 40.00
Catatonia After Neuroleptic Malignant Syndrome Successfully Treated With Electroconvulsive Therapy PDF quantity
$ 40.00
×
Satisfaction With Medication Is Correlated With Outcome but Not Persistence in Patients Treated With Placebo, Escitalopram, or Serotonin-Norepinephrine Reuptake Inhibitors: A Post Hoc Analysis PDF
$ 40.00
Satisfaction With Medication Is Correlated With Outcome but Not Persistence in Patients Treated With Placebo, Escitalopram, or Serotonin-Norepinephrine Reuptake Inhibitors: A Post Hoc Analysis PDF quantity
$ 40.00
×
Psychostimulant Use in Schizophrenia for Treatment of Negative Symptoms and Weight Loss PDF
$ 40.00
Psychostimulant Use in Schizophrenia for Treatment of Negative Symptoms and Weight Loss PDF quantity
$ 40.00
×
Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections Manifestations in a Teenager PDF
$ 40.00
Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections Manifestations in a Teenager PDF quantity
$ 40.00
×
Management of Individuals With Autism Spectrum Disorder in Clinical Settings PDF
$ 40.00
Management of Individuals With Autism Spectrum Disorder in Clinical Settings PDF quantity
$ 40.00
×
A Trial of Compliance Therapy in Outpatients With Schizophrenia or Schizoaffective Disorder PDF
$ 40.00
A Trial of Compliance Therapy in Outpatients With Schizophrenia or Schizoaffective Disorder PDF quantity
$ 40.00
×
Sudden Infant Death Syndrome and Maternal Depression PDF
$ 40.00
Sudden Infant Death Syndrome and Maternal Depression PDF quantity
$ 40.00
×
Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 2: Predictors of Relapse During the Continuation Phase of Pharmacotherapy PDF
$ 40.00
Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 2: Predictors of Relapse During the Continuation Phase of Pharmacotherapy PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart